New tech aims to sharpen radiation for kids with cancer

NCT ID NCT07528547

Recruiting now Knowledge-focused Sponsor: University Health Network, Toronto Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests two new technologies—HyperSight CBCT imaging and Ethos adaptive planning—in children receiving radiation for non-brain tumors. Twenty patients aged 18 or under will get extra scans twice a week to see if the radiation plan needs adjusting. The goal is to see if these tools can make treatment more precise and reduce side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HyperSight CBCT scans and Ethos adaptive radiation planning
What this could lead to: If successful, this could lead to more precise radiation delivery for children with cancer, potentially reducing damage to healthy tissues and improving treatment outcomes.
What could go wrong: This is a very small pilot study (20 patients) with no control group, so results may not apply broadly. The technology is still experimental and may not show clear benefits over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Princess Margaret Cancer Centre
RECRUITING

Toronto, Ontario, M5G 2M9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.